Literature DB >> 12140563

Screening for drug discovery: the leading question.

Adam Smith.   

Abstract

Mesh：

Year:  2002        PMID： 12140563     DOI： 10.1038/418453a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  21 in total

1.  A new method to predict flowability using a microscale fluid bed.

Authors:  Eetu Räsänen; Osmo Antikainen; Jouko Yliruusi
Journal:  AAPS PharmSciTech       Date:  2003-10-20       Impact factor: 3.246

Review 2.  Fragment-based QSAR: perspectives in drug design.

Authors:  Lívia B Salum; Adriano D Andricopulo
Journal:  Mol Divers       Date:  2009-01-31       Impact factor: 2.943

Review 3.  Structural features of mammalian histidine decarboxylase reveal the basis for specific inhibition.

Authors:  A A Moya-García; A Pino-Angeles; R Gil-Redondo; A Morreale; F Sánchez-Jiménez
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

4.  VSDMIP: virtual screening data management on an integrated platform.

Authors:  Rubén Gil-Redondo; Jorge Estrada; Antonio Morreale; Fernando Herranz; Javier Sancho; Angel R Ortiz
Journal:  J Comput Aided Mol Des       Date:  2008-10-22       Impact factor: 3.686

5.  Variety of antiprion compounds discovered through an in silico screen based on cellular-form prion protein structure: Correlation between antiprion activity and binding affinity.

Authors:  Junji Hosokawa-Muto; Yuji O Kamatari; Hironori K Nakamura; Kazuo Kuwata
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

6.  The importance of molecular complexity in the design of screening libraries.

Authors:  Shahul H Nilar; Ngai Ling Ma; Thomas H Keller
Journal:  J Comput Aided Mol Des       Date:  2013-09       Impact factor: 3.686

7.  Zebrafish screen identifies novel compound with selective toxicity against leukemia.

Authors:  Suzanne Ridges; Will L Heaton; Deepa Joshi; Henry Choi; Anna Eiring; Lance Batchelor; Priya Choudhry; Elizabeth J Manos; Hossein Sofla; Ali Sanati; Seth Welborn; Archana Agarwal; Gerald J Spangrude; Rodney R Miles; James E Cox; J Kimble Frazer; Michael Deininger; Kaveri Balan; Matthew Sigman; Markus Müschen; Tatiana Perova; Radia Johnson; Bertrand Montpellier; Cynthia J Guidos; David A Jones; Nikolaus S Trede
Journal:  Blood       Date:  2012-04-09       Impact factor: 22.113

8.  Drug inhibition profile prediction for NFκB pathway in multiple myeloma.

Authors:  Huiming Peng; Jianguo Wen; Hongwei Li; Jeff Chang; Xiaobo Zhou
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

9.  A Microdevice Platform Recapitulating Hypoxic Tumor Microenvironments.

Authors:  Yuta Ando; Hoang P Ta; Daniel P Yen; Sang-Sin Lee; Sneha Raola; Keyue Shen
Journal:  Sci Rep       Date:  2017-11-09       Impact factor: 4.996

10.  Rapid Discovery and Structure-Activity Relationships of Pyrazolopyrimidines That Potently Suppress Breast Cancer Cell Growth via SRC Kinase Inhibition with Exceptional Selectivity over ABL Kinase.

Authors:  Craig Fraser; John C Dawson; Reece Dowling; Douglas R Houston; Jason T Weiss; Alison F Munro; Morwenna Muir; Lea Harrington; Scott P Webster; Margaret C Frame; Valerie G Brunton; E Elizabeth Patton; Neil O Carragher; Asier Unciti-Broceta
Journal:  J Med Chem       Date:  2016-05-04       Impact factor: 7.446
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.